基本信息
views: 8
Career Trajectory
Bio
Prof. Wester’s (*1962) research focuses on the development of targeted radiolabelled probes and therapeutics (radiopharmaceuticals) for molecular imaging and targeted radioligand therapy. He has developed several methodological procedures and radiopharmaceuticals for oncological, neurological and cardiovascular investigations and therapies that have found broad application in clinical investigations and therapies.
Research Interests
Papers共 509 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Journal of nuclear medicine : official publication, Society of Nuclear Medicineno. 3 (2024): 493-494
EJNMMI RADIOPHARMACY AND CHEMISTRYno. 1 (2024)
Nadine Holzleitner,Sebastian Fischer, Isabel Maniyankerikalam,Roswitha Beck,Constantin Lapa,Hans-Jürgen Wester,Thomas Günther
EJNMMI Researchno. 1 (2024): 1-12
EJNMMI RESEARCHno. 1 (2023)
PHARMACEUTICSno. 3 (2023): 826-826
openalex(2023)
Ingo Hartlapp,Philipp E. Hartrampf,Sebastian E. Serfling,Vanessa Wild,Alexander Weich,Leo Rasche,Sabine Roth,Andreas Rosenwald,Patrick W. Mihatsch,Anne Hendricks,Armin Wiegering,Verena Wiegering,Heribert Haenscheid,Andreas Schirbel,Rudolf A. Werner,Andreas K. Buck,Hans-Juergen Wester,Hermann Einsele,Volker Kunzmann,Constantin Lapa,K. Martin Kortuem
The Journal of nuclear medicineno. 9 (2023): 1424-1430
Load More
Author Statistics
#Papers: 505
#Citation: 29232
H-Index: 93
G-Index: 153
Sociability: 7
Diversity: 3
Activity: 59
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn